SMS Lifesciences India Ltd.
NSE: SMSLIFE | BSE: 540679
₹1,631.50
₹-28.20
(-1.70%)
As on 27-May-2026IST
Market cap
₹493 Cr
Revenue (TTM)
₹348 Cr
P/E Ratio
24.8
P/B Ratio
2.3
Div. Yield
0.1 %
Quality Score
3/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹20 Cr
-
ROE
10 %
-
ROCE
12.6 %
-
Industry P/E
36.8
-
EV/EBITDA
11
-
Debt to Equity
0.4
-
Book Value
₹704.8
-
EPS
₹65.7
-
Face value
10
-
Shares outstanding
3,023,287
10 Years Aggregate
CFO
₹169.18 Cr
EBITDA
₹271.79 Cr
Net Profit
₹122.77 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SMS Lifesciences
| 23.2 | 17.6 | 24.3 | 20.0 | 43.0 | 22.3 | -- |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
SMS Lifesciences
| 10.4 | 122.7 | -15.3 | -14.5 | 18.3 | 147.1 | -45.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
SMS Lifesciences
|
1,631.5 | 492.8 | 347.8 | 20.9 | 9.0 | 9.9 | 24.8 | 2.3 |
| 1,070.3 | 13,138.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23.3 | 3.9 | |
| 470.3 | 8,160.7 | 947.3 | 247.8 | 28.5 | 18.9 | 32.9 | 6.0 | |
| 1,099.6 | 11,501.5 | 1,158.7 | 309.6 | 31.9 | 17.3 | 36.8 | 6.1 | |
| 1,725.3 | 32,703.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.4 | 6.6 | |
| 432.2 | 4,723.6 | 165.8 | 46.7 | 37.8 | 16.9 | 101.2 | 16.4 | |
| 16,772.0 | 21,502.1 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.1 | 11.5 | |
| 1,113.4 | 5,129.2 | 649.5 | 121.6 | 23.7 | 13.2 | 44.5 | 5.5 | |
| 674.7 | 7,616.1 | 502.0 | 138.7 | -- | 32.8 | 44.1 | 8.6 | |
| 267.2 | 7,038.7 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About SMS Lifesciences
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction,... anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India. Read more
-
Incorporated
2006
-
Chairman
--
-
Managing Director
TVVSN Murthy
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsEncumbrance (Annual Disclosure)
08-Apr-2026Annual Confirmation (Reclassification)
08-Apr-2026Events Calendar (Postal Ballot)
26-Mar-2026No News & Announcements are available.
FAQs for SMS Lifesciences
What is the current share price of SMS Lifesciences India Ltd Today?
The share price of SMS Lifesciences India Ltd is ₹1,631.50 (NSE) and ₹1,630.00 (BSE) as of 27-May-2026 IST. SMS Lifesciences India Ltd has given a return of 43.02% in the last 3 years.
What is the current PB & PE ratio of SMS Lifesciences India Ltd?
The P/E ratio of SMS Lifesciences India Ltd is 24.83 times as on 27-May-2026, a 33 discount to its peers’ median range of 36.80 times.
The P/B ratio of SMS Lifesciences India Ltd is 2.31 times as on 27-May-2026, a 0 premium to its peers’ median range of 2.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.24
|
1.66
|
|
2024
|
22.57
|
1.16
|
|
2023
|
13.71
|
0.93
|
|
2022
|
8.30
|
1.38
|
|
2021
|
11.04
|
1.16
|
What is the 52 Week High and Low of SMS Lifesciences India Ltd?
The 52-week high and low of SMS Lifesciences India Ltd are Rs 1,774.00 and Rs 1,067.00 as of 28-May-2026.
What is the market cap of SMS Lifesciences India Ltd?
SMS Lifesciences India Ltd has a market capitalisation of ₹ 493 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in SMS Lifesciences India Ltd?
Before investing in SMS Lifesciences India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.